Albinism and disease causing pathogens in Tanzania: Are alleles that are associated with OCA2 being maintained by balancing selection?

Medical Hypotheses

Volumn 79, Issue 6, 2012, Pages 875-878

  Tuli, Abbas M ^a,b   Valenzuela, Robert K ^a,c   Kamugisha, Erasmus ^d   Brilliant, Murray H ^a,c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MARSHFIELD CLINIC   (United States)

^d CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRANSPORT INTEGRAL MEMBRANE PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BALANCING SELECTION; GENE DELETION; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; HYPOPIGMENTATION; LEPROSY; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; OCULOCUTANEOUS ALBINISM; PHARMACOGENETICS; TANZANIA;

ALBINISM; ALLELES; HUMANS; MEMBRANE TRANSPORT PROTEINS; MODELS, THEORETICAL; SELECTION, GENETIC; TANZANIA;

MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 84869083327     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.09.013     Document Type: Article

References (25)

1. Witkop C.J. Albinism. Clin Dermatol 1989, 7:80-91.
2. Spritz R.A., Fukai K., Holmes S.A., Luande J. Frequent intragenic deletion of the P gene in Tanzanian patients with type ii oculocutaneous albinism (OCA2). Am J Hum Genet 1995, 56:1320-1323.
3. Spritz R.A., Hearing V.J. Genetic disorders of pigmentation. Adv Hum Genet 1994, 22:1-45.
4. Hong E.S., Zeeb H., Repacholi M.H. Albinism in Africa as a public health issue. BMC Public Health 2006, 6:212.
5. Lookingbill D.P., Lookingbill G.L., Leppard B. Actinic damage and skin cancer in albinos in Northern Tanzania: findings in 164 patients enrolled in an outreach skin care program. J Am Acad Dermatol 1995, 32:653-658.
6. Durham-Pierre D., Gardner J.M., Nakatsu Y., et al. African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism. Nat Genet 1994, 7:176-179.
7. Jablonski N.G., Chaplin G. Colloquium paper: human skin pigmentation as an adaptation to UV radiation. Proc Natl Acad Sci USA 2010, 107:8962-8968.
8. Puri N., Gardner J.M., Brilliant M.H. Aberrant pH of melanosomes in pink-eyed dilution (p) mutant melanocytes. J Invest Dermatol 2000, 115:607-613.
9. Stevens G., Ramsay M., Jenkins T. Oculocutaneous albinism (OCA2) in sub-Saharan Africa: distribution of the common 2.7-kb P gene deletion mutation. Hum Genet 1997, 99:523-527.
10. Aquaron R., Soufir N., Berge-Lefranc J.-L., Badens C., Austerlitz F., Grandchamp B. Oculocutaneous albinism type 2 (OCA2) with homozygous 2.7-kb deletion of the P gene and sickle cell disease in a Cameroonian family. Identification of a common TAG haplotype in the mutated P gene. J Hum Genet 2007, 52:771-780.
11. Luande J., Henschke C.I., Mohammed N. The Tanzanian human albino skin. Natural history. Cancer 1985, 55:1823-1828.
12. Worobec S.M. Treatment of leprosy/Hansen's disease in the early 21st century. Dermatol Ther 2009, 22:518-537.
13. Aridon P., Ragonese P., Mazzola M.A., et al. Leprosy: report of a case with severe peripheral neuropathy. Neurol Sci 2010, 31:75-77.
14. Oskam L., Hartskeerl R.A., Hermans C.J., et al. A 46kDa integral membrane protein from Mycobacterium leprae resembles a number of bacterial and mammalian membrane transport proteins. Microbiology 1995, 141:1963-1968.
15. Valenzuela R.K., Henderson M.S., Walsh M.H., et al. Predicting phenotype from genotype: normal pigmentation. J Forensic Sci 2010, 55:315-322.
16. Faul F., Erdfelder E., Buchner A., Lang A.-G. Statistical power analyses using GPower 3.1: tests for correlation and regression analyses. Behav Res Methods 2009, 41:1149-1160.
17. Allison A.C. Genetic factors in resistance to malaria. Ann NY Acad Sci 1961, 91:710-729.
18. Allison A.C. Protection afforded by sickle-cell trait against subtertian malarial infection. Br Med J 1954, 1:290-294.
19. Ringelhann B., Hathorn M.K., Jilly P., Grant F., Parniczky G. A new look at the protection of hemoglobin AS and AC genotypes against Plasmodium falciparum infection: a census tract approach. Am J Hum Genet 1976, 28:270-279.
20. Finnie R.K., Khoza L.B., van den Borne B., Mabunda T., Abotchie P., Mullen P.D. Factors associated with patient and health care system delay in diagnosis and treatment for TB in sub-Saharan African countries with high burdens of TB and HIV. Trop Med Int Health 2011, 16:394-411.
21. Cervino A.C., Lakiss S., Sow O., et al. Fine mapping of a putative tuberculosis-susceptibility locus on chromosome 15q11-13 in African families. Hum Mol Genet 2002, 11:1599-1603.
22. Clayton-Smith J., Laan L. Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet 2003, 40:87-95.
23. Hackam D.J., Rotstein O.D., Zhang W., Gruenheid S., Gros P., Grinstein S. Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J Exp Med 1998, 188:351-364.
24. Jabado N., Jankowski A., Dougaparsad S., Picard V., Grinstein S., Gros P. Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J Exp Med 2000, 192:1237-1248.
25. Hodgkin J. Seven types of pleiotropy. Int J Dev Biol 1998, 42:501-505.